Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Apnea, Obstructive | 19 | 2025 | 219 | 5.700 |
Why?
|
| Sleep | 22 | 2025 | 448 | 3.810 |
Why?
|
| Continuous Positive Airway Pressure | 7 | 2025 | 54 | 2.090 |
Why?
|
| Sleep Deprivation | 10 | 2017 | 125 | 1.530 |
Why?
|
| Obesity | 14 | 2025 | 1018 | 1.490 |
Why?
|
| Insulin Resistance | 13 | 2016 | 379 | 1.400 |
Why?
|
| Blood Glucose | 12 | 2023 | 867 | 1.330 |
Why?
|
| Diabetes Mellitus, Type 2 | 10 | 2023 | 1229 | 1.310 |
Why?
|
| Prediabetic State | 3 | 2020 | 42 | 1.170 |
Why?
|
| Sleep Medicine Specialty | 4 | 2015 | 9 | 1.150 |
Why?
|
| Glucose | 4 | 2023 | 692 | 1.120 |
Why?
|
| Overweight | 2 | 2022 | 120 | 1.060 |
Why?
|
| Energy Intake | 3 | 2022 | 97 | 0.930 |
Why?
|
| Health | 3 | 2015 | 27 | 0.930 |
Why?
|
| Ghrelin | 4 | 2015 | 27 | 0.920 |
Why?
|
| Circadian Rhythm | 5 | 2016 | 285 | 0.920 |
Why?
|
| Consensus | 4 | 2015 | 368 | 0.910 |
Why?
|
| Eating | 3 | 2016 | 162 | 0.870 |
Why?
|
| Sleep Wake Disorders | 4 | 2016 | 124 | 0.770 |
Why?
|
| Weight Loss | 2 | 2022 | 234 | 0.760 |
Why?
|
| Polysomnography | 11 | 2021 | 153 | 0.740 |
Why?
|
| Polycystic Ovary Syndrome | 3 | 2010 | 193 | 0.730 |
Why?
|
| Diet, Mediterranean | 1 | 2022 | 6 | 0.720 |
Why?
|
| Academies and Institutes | 4 | 2015 | 33 | 0.710 |
Why?
|
| Rest | 1 | 2020 | 50 | 0.650 |
Why?
|
| Heart Rate | 2 | 2020 | 505 | 0.610 |
Why?
|
| Hypertension | 1 | 2025 | 757 | 0.610 |
Why?
|
| Telemedicine | 1 | 2022 | 225 | 0.600 |
Why?
|
| Insulin | 7 | 2021 | 1185 | 0.590 |
Why?
|
| Diabetes Mellitus | 2 | 2025 | 767 | 0.570 |
Why?
|
| Glycerides | 2 | 2016 | 13 | 0.560 |
Why?
|
| Arachidonic Acids | 2 | 2016 | 36 | 0.560 |
Why?
|
| Endocannabinoids | 2 | 2016 | 27 | 0.550 |
Why?
|
| Diet | 4 | 2025 | 460 | 0.520 |
Why?
|
| Humans | 49 | 2025 | 93515 | 0.510 |
Why?
|
| Vegetables | 3 | 2025 | 50 | 0.500 |
Why?
|
| Cardiovascular Diseases | 3 | 2020 | 754 | 0.500 |
Why?
|
| Adult | 27 | 2025 | 27918 | 0.490 |
Why?
|
| Young Adult | 14 | 2025 | 6930 | 0.470 |
Why?
|
| Societies, Scientific | 1 | 2015 | 41 | 0.450 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2015 | 67 | 0.440 |
Why?
|
| Risk Factors | 14 | 2025 | 5899 | 0.440 |
Why?
|
| Patient Compliance | 3 | 2022 | 237 | 0.390 |
Why?
|
| Thinness | 1 | 2012 | 45 | 0.370 |
Why?
|
| Glucose Intolerance | 2 | 2010 | 100 | 0.340 |
Why?
|
| Motivation | 1 | 2014 | 310 | 0.340 |
Why?
|
| Male | 25 | 2025 | 44557 | 0.330 |
Why?
|
| Body Mass Index | 4 | 2022 | 811 | 0.330 |
Why?
|
| Fruit | 2 | 2025 | 81 | 0.320 |
Why?
|
| Research | 3 | 2015 | 251 | 0.310 |
Why?
|
| Metabolic Syndrome | 2 | 2008 | 122 | 0.290 |
Why?
|
| Sleep Stages | 2 | 2008 | 45 | 0.280 |
Why?
|
| Dietary Fats | 2 | 2022 | 135 | 0.280 |
Why?
|
| Female | 22 | 2025 | 48702 | 0.280 |
Why?
|
| Appetite | 3 | 2015 | 21 | 0.280 |
Why?
|
| Time Factors | 6 | 2015 | 5410 | 0.280 |
Why?
|
| Leptin | 3 | 2015 | 100 | 0.270 |
Why?
|
| Hydrocortisone | 5 | 2017 | 296 | 0.260 |
Why?
|
| Dietary Carbohydrates | 2 | 2022 | 39 | 0.260 |
Why?
|
| Pituitary-Adrenal System | 3 | 2017 | 64 | 0.250 |
Why?
|
| Dietary Proteins | 2 | 2017 | 31 | 0.240 |
Why?
|
| Actigraphy | 3 | 2025 | 61 | 0.230 |
Why?
|
| Adolescent | 8 | 2021 | 9606 | 0.230 |
Why?
|
| Respiratory Mechanics | 1 | 2005 | 108 | 0.220 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2024 | 36 | 0.220 |
Why?
|
| Energy Metabolism | 4 | 2017 | 299 | 0.210 |
Why?
|
| Blood Pressure Determination | 1 | 2024 | 69 | 0.210 |
Why?
|
| Wearable Electronic Devices | 1 | 2024 | 36 | 0.210 |
Why?
|
| Sleep Disorders, Intrinsic | 1 | 2023 | 5 | 0.200 |
Why?
|
| Human Growth Hormone | 3 | 2015 | 51 | 0.190 |
Why?
|
| Middle Aged | 11 | 2024 | 27573 | 0.180 |
Why?
|
| Glucose Tolerance Test | 4 | 2017 | 232 | 0.180 |
Why?
|
| Dietary Fiber | 1 | 2022 | 46 | 0.180 |
Why?
|
| Disease Outbreaks | 1 | 2002 | 150 | 0.170 |
Why?
|
| Healthy Volunteers | 3 | 2017 | 148 | 0.160 |
Why?
|
| Blood Pressure | 1 | 2024 | 896 | 0.160 |
Why?
|
| Proof of Concept Study | 1 | 2020 | 56 | 0.160 |
Why?
|
| United States | 5 | 2016 | 7622 | 0.160 |
Why?
|
| Biomarkers | 3 | 2015 | 1910 | 0.160 |
Why?
|
| Monitoring, Physiologic | 1 | 2020 | 262 | 0.150 |
Why?
|
| Random Allocation | 2 | 2017 | 307 | 0.140 |
Why?
|
| Area Under Curve | 2 | 2010 | 335 | 0.130 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2017 | 40 | 0.130 |
Why?
|
| Electroencephalography | 4 | 2017 | 797 | 0.120 |
Why?
|
| Enterocytes | 1 | 2016 | 27 | 0.120 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2014 | 80 | 0.120 |
Why?
|
| Hyperphagia | 1 | 2016 | 35 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2021 | 589 | 0.120 |
Why?
|
| Body Weight | 1 | 2017 | 449 | 0.120 |
Why?
|
| Intestinal Absorption | 1 | 2016 | 125 | 0.120 |
Why?
|
| Postprandial Period | 2 | 2016 | 47 | 0.110 |
Why?
|
| Fasting | 2 | 2016 | 163 | 0.110 |
Why?
|
| Norepinephrine | 1 | 2015 | 169 | 0.110 |
Why?
|
| Food, Organic | 1 | 2014 | 3 | 0.110 |
Why?
|
| Food Preferences | 1 | 2014 | 27 | 0.110 |
Why?
|
| Cross-Over Studies | 4 | 2017 | 390 | 0.100 |
Why?
|
| Animals | 5 | 2025 | 28155 | 0.100 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 436 | 0.100 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 3830 | 0.100 |
Why?
|
| Health Promotion | 1 | 2015 | 170 | 0.100 |
Why?
|
| Health Status | 2 | 2005 | 377 | 0.100 |
Why?
|
| Choice Behavior | 1 | 2014 | 159 | 0.100 |
Why?
|
| Oxidative Stress | 1 | 2016 | 467 | 0.100 |
Why?
|
| ROC Curve | 1 | 2015 | 775 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2015 | 730 | 0.090 |
Why?
|
| Aged | 6 | 2024 | 20434 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2012 | 4560 | 0.090 |
Why?
|
| Societies, Medical | 1 | 2015 | 621 | 0.090 |
Why?
|
| Comorbidity | 2 | 2008 | 1007 | 0.090 |
Why?
|
| Adipocytes | 1 | 2012 | 169 | 0.090 |
Why?
|
| Hunger | 2 | 2016 | 20 | 0.080 |
Why?
|
| Acylation | 1 | 2010 | 68 | 0.080 |
Why?
|
| Autonomic Nervous System | 1 | 2010 | 67 | 0.080 |
Why?
|
| Hormones | 1 | 2010 | 136 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2017 | 1931 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2009 | 181 | 0.070 |
Why?
|
| Snoring | 1 | 2008 | 12 | 0.070 |
Why?
|
| Electrocardiography | 1 | 2010 | 493 | 0.070 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2008 | 53 | 0.070 |
Why?
|
| Arousal | 1 | 2008 | 171 | 0.070 |
Why?
|
| Hemodynamics | 1 | 2010 | 713 | 0.060 |
Why?
|
| Brain | 1 | 2017 | 2391 | 0.060 |
Why?
|
| Neurosecretory Systems | 1 | 2007 | 35 | 0.060 |
Why?
|
| Delta Rhythm | 1 | 2005 | 18 | 0.060 |
Why?
|
| Prolactin | 1 | 2005 | 89 | 0.060 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2017 | 124 | 0.060 |
Why?
|
| Blood Pressure Monitors | 1 | 2024 | 9 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 1917 | 0.050 |
Why?
|
| Peptide Hormones | 1 | 2004 | 30 | 0.050 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2005 | 106 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 7061 | 0.050 |
Why?
|
| Self Report | 1 | 2025 | 328 | 0.050 |
Why?
|
| Equipment Design | 1 | 2024 | 416 | 0.050 |
Why?
|
| Glucokinase | 1 | 2023 | 61 | 0.050 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2023 | 80 | 0.050 |
Why?
|
| Hypoxia | 1 | 2008 | 675 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2015 | 9099 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2024 | 702 | 0.050 |
Why?
|
| Inflammation | 1 | 2008 | 1050 | 0.040 |
Why?
|
| Behcet Syndrome | 1 | 2001 | 15 | 0.040 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2021 | 62 | 0.040 |
Why?
|
| Insulin Infusion Systems | 1 | 2021 | 44 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2001 | 283 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2005 | 3054 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 2715 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2021 | 379 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2005 | 2802 | 0.030 |
Why?
|
| Adiposity | 1 | 2017 | 76 | 0.030 |
Why?
|
| Sheep | 1 | 2017 | 203 | 0.030 |
Why?
|
| Body Composition | 1 | 2017 | 74 | 0.030 |
Why?
|
| Appetite Regulation | 1 | 2016 | 7 | 0.030 |
Why?
|
| Pedigree | 1 | 2017 | 961 | 0.030 |
Why?
|
| Wakefulness | 1 | 2016 | 131 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2016 | 124 | 0.030 |
Why?
|
| Risk | 1 | 2016 | 657 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2017 | 342 | 0.030 |
Why?
|
| Reward | 1 | 2016 | 209 | 0.030 |
Why?
|
| Sex Factors | 2 | 2005 | 1105 | 0.020 |
Why?
|
| Mutation | 1 | 2023 | 4272 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2012 | 366 | 0.020 |
Why?
|
| Carbohydrate Metabolism | 1 | 2008 | 31 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 1914 | 0.020 |
Why?
|
| Sleep, REM | 1 | 2008 | 49 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 2495 | 0.020 |
Why?
|
| Glucaric Acid | 1 | 2005 | 5 | 0.010 |
Why?
|
| Vagus Nerve | 1 | 2005 | 45 | 0.010 |
Why?
|
| Alpha Rhythm | 1 | 2005 | 27 | 0.010 |
Why?
|
| Sympathetic Nervous System | 1 | 2005 | 99 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 3502 | 0.010 |
Why?
|
| Hemoptysis | 1 | 2001 | 25 | 0.010 |
Why?
|
| Pulmonary Circulation | 1 | 2001 | 92 | 0.010 |
Why?
|
| Aneurysm | 1 | 2001 | 57 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2001 | 333 | 0.010 |
Why?
|
| Thrombolytic Therapy | 1 | 2001 | 254 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2001 | 761 | 0.010 |
Why?
|
| Prognosis | 1 | 2001 | 3911 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2001 | 2585 | 0.010 |
Why?
|